Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 342

1.

Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations.

Davidson MH, Maki KC, Pearson TA, Pasternak RC, Deedwania PC, McKenney JM, Fonarow GC, Maron DJ, Ansell BJ, Clark LT, Ballantyne CM.

Am J Cardiol. 2005 Aug 15;96(4):556-63.

PMID:
16098311
2.

Reduced treatment success in lipid management among women with coronary heart disease or risk equivalents: results of a national survey.

Ansell BJ, Fonarow GC, Maki KC, Dicklin MR, Bell M, Davidson MH; NEPTUNE II Steering Committee.

Am Heart J. 2006 Nov;152(5):976-81.

PMID:
17070174
3.

Non-high-density lipoprotein cholesterol: the forgotten therapeutic target.

Maki KC, Galant R, Davidson MH.

Am J Cardiol. 2005 Nov 7;96(9A):59K-64K; discussion 34K-35K. Epub 2005 Oct 21. Review.

PMID:
16291016
5.
6.

Implications from the Air Force/Texas Coronary Atherosclerosis Prevention Study for the Adult Treatment Panel III guidelines.

Clearfield M, Downs JR, Lee M, Langendorfer A, McConathy W, Gotto AM Jr.

Am J Cardiol. 2005 Dec 15;96(12):1674-80. Epub 2005 Nov 2.

PMID:
16360356
8.
9.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

J Am Coll Cardiol. 2004 Aug 4;44(3):720-32. Review.

10.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):e149-61. Review.

11.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association.

Circulation. 2004 Jul 13;110(2):227-39. Review. Erratum in: Circulation. 2004 Aug 10;110(6):763.

12.

New guidelines for managing hypercholesterolemia.

McKenney JM.

J Am Pharm Assoc (Wash). 2001 Jul-Aug;41(4):596-607. Erratum in: J Am Pharm Assoc (Wash) 2002 Mar-Apr;42(2):157.

PMID:
11486986
13.
15.

Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.

Daskalopoulou SS, Mikhailidis DP.

Curr Med Res Opin. 2006 Mar;22(3):511-28. Review.

PMID:
16574035
16.

Implications of changing national cholesterol education program goals for the treatment and control of hypercholesterolemia.

Persell SD, Lloyd-Jones DM, Baker DW.

J Gen Intern Med. 2006 Feb;21(2):171-6. Epub 2005 Dec 22.

17.
18.

The A-SACT (Achievement in Singapore of Cholesterol Targets) study in patients with coronary heart disease.

Ho KT, Chin KW, Ng KS, Alemao E, Rajagopalan S, Yin D.

Am J Cardiovasc Drugs. 2006;6(6):383-91.

PMID:
17192128
19.

National improvements in low-density lipoprotein cholesterol management of individuals at high coronary risk: National Health and Nutrition Examination Survey, 1999 to 2002.

Cullen MW, Stein JH, Gangnon R, McBride PE, Keevil JG.

Am Heart J. 2008 Aug;156(2):284-91. doi: 10.1016/j.ahj.2008.03.004. Epub 2008 Jun 4.

PMID:
18657658

Supplemental Content

Support Center